1h
Hosted on MSNFormer Top Drug Regulator Lands Cushy Pfizer Gig After Leaving FDA During Trump TransitionPatrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, ...
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
Recalled supplemental shakes were distributed to hospitals and long-term care facilities nationwide, federal officials say.
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...
The widespread use of antibiotics in industrial animal agriculture is contributing to the rise of antibiotic resistance, with ...
Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
As part of a bipartisan coalition of 38 states and territories, California Attorney General Rob Bonta today urged the Food and Drug Administration (FDA) to take swift and decisive action against bad ...
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results